REPORTS

Let’s Pullulate and Expand Your Business

Pneumonia Vaccine Market - Global Professional Analysis and Forecast to 2026

Mar 13, 2020  |  195 PAGES  |  REPORT CODE: CMM271692
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pneumonia Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period.

This report presents the market size and development trends by detailing the Pneumonia Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pneumonia Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pneumonia Vaccine industry and will help you to build a panoramic view of the industrial development.

Pneumonia Vaccine Market, By Type:

  • Pneumococcal Conjugate Vaccine (PCV13)

  • Pneumococcal Polysaccharide Vaccine (PPSV23)

Pneumonia Vaccine Market, By Application:

  • Pneumonia

  • Meningitis

  • Sepsis

Some of the leading players are as follows:

  • Johnson & Johnson

  • Emergent Biosolutions

  • CSL Limited

  • Sanofi Pasteur

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pneumonia Vaccine Market: Technology Type Analysis

  • 4.1 Pneumonia Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pneumonia Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pneumococcal Conjugate Vaccine (PCV13)

    • 4.3.2 Pneumococcal Polysaccharide Vaccine (PPSV23)

5 Pneumonia Vaccine Market: Product Analysis

  • 5.1 Pneumonia Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Pneumonia Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pneumonia Vaccine Market: Application Analysis

  • 6.1 Pneumonia Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Pneumonia Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pneumonia

    • 6.3.2 Meningitis

    • 6.3.3 Sepsis

7 Pneumonia Vaccine Market: Regional Analysis

  • 7.1 Pneumonia Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pneumonia Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Johnson & Johnson

    • 9.1.1 Johnson & Johnson Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Emergent Biosolutions

    • 9.2.1 Emergent Biosolutions Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 CSL Limited

    • 9.3.1 CSL Limited Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sanofi Pasteur

    • 9.4.1 Sanofi Pasteur Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

 

The List of Tables and Figures (Totals 62 Figures and 125 Tables)

  • Figure Pneumococcal Conjugate Vaccine (PCV13) Pneumonia Vaccine market, 2015 - 2026 (USD Million)

  • Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Pneumonia Vaccine market, 2015 - 2026 (USD Million)

  • Figure Pneumonia market, 2015 - 2026 (USD Million)

  • Figure Meningitis market, 2015 - 2026 (USD Million)

  • Figure Sepsis market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pneumonia Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pneumonia Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumonia Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pneumonia Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pneumonia Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pneumonia Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pneumonia Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pneumonia Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emergent Biosolutions Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CSL Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top